Open AccessMaribavir for Treatment of Cytomegalovirus (CMV) Infections Resistant or Refractory to Ganciclovir or Foscarnet in Hematopoietic Stem Cell Transplant (SCT) or Solid Organ Transplant (SOT) Recipients: A Randomized, Dose-Ranging, Double-Blind, Phase 2 Study
Author(s) -
Genovefa A. Papanicolaou,
Fernanda P. Silveira,
Amelia Langston,
Marcus R. Pereira,
Robin K. Avery,
Anna Wijatyk,
Jingyang J Wu,
Michael Boeckh,
Francisco M. Marty,
Stephen Villano
Publication year - 2016
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofw194.13
Subject(s) - foscarnet , ganciclovir , medicine , refractory (planetary science) , cytomegalovirus , virology , bone marrow transplant , dose ranging study , transplantation , valganciclovir , double blind , human cytomegalovirus , placebo , virus , herpesviridae , viral disease , pathology , bone marrow transplantation , biology , astrobiology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom